Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice-Reference-Cited by-同舟云学术

Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice

Published:2014-03-05 Issue:6 Volume:28 Page:2655-2666
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Benesch Matthew G. K.¹,Tang Xiaoyun¹,Maeda Tatsuo²,Ohhata Akira³,Zhao Yuan Y.⁴,Kok Bernard P. C.¹,Dewald Jay¹,Hitt Mary⁵,Curtis Jonathan M.⁴,McMullen Todd P. W.⁶,Brindley David N.¹

Affiliation:

1. Signal Transduction Research GroupDepartment of BiochemistryUniversity of AlbertaEdmontonAlbertaCanada

2. Exploration Research LaboratoriesOno Pharmaceuticals CompanyTsukubaJapan

3. Medicinal Chemistry Research LaboratoriesOno Pharmaceuticals CompanyShimamotoJapan

4. Department of Agricultural, Food, and Nutritional ScienceUniversity of AlbertaEdmontonAlbertaCanada

5. Department of OncologyUniversity of AlbertaEdmontonAlbertaCanada

6. Department of SurgeryMackenzie Health Science CentreUniversity of AlbertaEdmontonAlbertaCanada

Funder

Congressional Black Caucus Foundation

Canadian Institutes of Health Research

Alberta Cancer Foundation

Ono Pharmaceutical

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.13-248641

Reference63 articles.

1. Cancer Statistics, 2006

2. Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over

3. Role of autotaxin and lysophosphatidate in cancer progression and resistance to chemotherapy and radiotherapy

4. Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy

5. Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications;International Journal of Molecular Sciences;2024-07-15

2. Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer;World Journal of Oncology;2024-02

3. A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer;Communications Biology;2024-01-05

4. Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression;American Journal of Cancer Research;2024

5. Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs;Cancers;2023-12-21